Lb Pharmaceuticals (LBRX) Free Cash Flow (2024 - 2026)

Lb Pharmaceuticals' Free Cash Flow history runs 3 years deep, the most recent figure standing at -$23.3 million for Q1 2026.

• In Q1 2026, Free Cash Flow fell 186.32% year-over-year to -$23.3 million; the TTM figure through Mar 2026 stood at -$49.6 million (changed N/A YoY), while the FY2025 annual figure was -$35.3 million, up 34.5% from the prior year.
• Free Cash Flow for Q1 2026 stood at -$23.3 million, down from -$18.1 million in the prior quarter.
• The five-year high for Free Cash Flow was -$5.9 million in Q4 2024, with the low at -$23.3 million in Q1 2026.
• The 3-year median for Free Cash Flow is -$13.1 million (2025), against an average of -$13.9 million.
• The sharpest annual moves came in 2025 and 2026: Free Cash Flow tumbled 207.3% in 2025, then sank 186.32% in 2026.
• Lb Pharmaceuticals' Free Cash Flow stood at -$5.9 million in 2024, then sank by 207.3% to -$18.1 million in 2025, then fell by 28.62% to -$23.3 million in 2026.
• Business Quant data shows LBRX's Free Cash Flow at -$23.3 million in Q1 2026, -$18.1 million in Q4 2025, and -$8.1 million in Q1 2025.